Clinical trial
Gamma-band High-definition Transcranial Alternating Current Stimulation (HD-tACS) for Sleep Disturbances in Mild Neurocognitive Disorders Due to Alzheimer's Disease
NCT05544201 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gamma-band High-definition Transcranial Alternating Current Stimulation (HD-tACS) for Sleep Disturbances in Mild Neurocognitive Disorders Due to Alzheimer's Disease
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2022
- Completion date
- February 28, 2024
- Enrollment
- 99 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, alzheimer disease, brain stimulation, cognitive impairment, mild, sleep disturbance, tacs